Skip to main content
OpenTrials
Completed

NCT Number: NCT06683495

Effect of Mirror Therapy on the Arteriovenous Fistula Cannulation-related Pain and Anxiety

Pharmacological and non-pharmacological methods are frequently used to reduce cannulation-related pain in patients with fistulas. Non-pharmacological approaches have been more favored than pharmacological approaches for some reasons, including ease of use and fewer side effects. Patients describe worry about the success of needling and resigned acceptance of pain and anxiety about dialysis needles. With this background in mind, mirror therapy has been introduced as one of the non-pharmacological interventions in the domain of pain management.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Istanbul University

Istanbul, Turkey (Türkiye)

About this study

Patients undergoing hemodialysis experience pain, anxiety and stress due to large-gauge needle punctures necessary to ensure efficient arteriovenous fistula flow. In addition, anxiety disorders are prevalent in hemodialysis patients, primarily caused by invasive procedures and dialysis machine alarm sounds. Patients describe worry about the success of needling and resigned acceptance of pain and anxiety about dialysis needles. Therefore, when performing an AVF puncture, nursing care should prioritise the management of pain and anxiety. With this background in mind, mirror therapy has been introduced as one of the non-pharmacological interventions in the domain of pain management. It has been reported that viewing the picture of a healthy limb could moderate pain perception in the affected one

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18 years and older
  • Patients who received hemodialysis (HD) treatment with an arteriovenous fistula (AVF) for at least 3 months
  • Patients receiving HD treatment 3 days a week for 4 hours each session
  • Patients with a pain score of ⩾1 during AVF cannulation, measured by a visual analog scale (VAS)
  • Patients able to communicate in Turkish
  • Patients without psychiatric disorders that impair communication
  • Patients who agreed to participate in the study

Exclusion criteria

  • Patients who were known to present difficulties with fistula cannulation (requiring multiple cannulations)
  • Patients with a history of hematoma or stenosis in the arteriovenous fistula (AVF)
  • Patients with an infection at the fistula site
  • Patients who took painkillers within 3 hours prior to treatment
  • Patients unable to maintain a sitting position on the bed
  • Patients with low vision or visual disturbances (30 cm or less)
  • Patients who did not wish to participate in the study

Treatment and study plan

Mirror Therapy

Other

For mirror therapy, a 50×40 cm mirror will be used

Primary outcomes

  1. Change From Baseline Fistula Cannulation Related Pain

    Time frame: Up to 2 weeks (3 hemodialysis sessions in a week)

    It will be assessed six times at the end of the dialysis session with Visual Analogue Scale. Visual Analogue Scale ranging from 0 (no pain) to 10 (worst pain). Pain increases the score increases. The high point describes bad outcome

  2. Change From Baseline Anxiety at Six Sessions

    Time frame: Up to 2 weeks ( 3 hemodialysis sessions in a week)

    It will be assessed with State-Trait Anxiety Inventory. This scale, which has a two-factor structure is comprised of 40 items. Twenty of these items assess the state anxiety status and the other 20 items assess trait anxiety. Each item is scored on a four-point scale. Total score ranges between 20 and 80 for anxiety. A high score indicates a high level of anxiety.

Sponsors and collaborators

Lead sponsor

Istanbul University

Other

Registry information

Official study title

Effect of Mirror Therapy on the Arteriovenous Fistula Cannulation-related Pain and Anxiety: A Prospective, Single Blind Randomized Controlled Study

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Nov 12, 2024
Registry last updated
May 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.